Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Inflammatory pseudotumor of pelvic lymph nodes.
Spannuth WA, Leath CA 3rd, Conner MG, Alvarez RD. Spannuth WA, et al. Obstet Gynecol. 2006 Sep;108(3 Pt 2):779-82. doi: 10.1097/01.AOG.0000201973.13715.ee. Obstet Gynecol. 2006. PMID: 17018500
Farletuzumab in epithelial ovarian carcinoma.
Spannuth WA, Sood AK, Coleman RL. Spannuth WA, et al. Expert Opin Biol Ther. 2010 Mar;10(3):431-7. doi: 10.1517/14712591003592069. Expert Opin Biol Ther. 2010. PMID: 20092424 Review.
Anti-angiogenic properties of metronomic topotecan in ovarian carcinoma.
Merritt WM, Danes CG, Shahzad MM, Lin YG, Kamat AA, Han LY, Spannuth WA, Nick AM, Mangala LS, Stone RL, Kim HS, Gershenson DM, Jaffe RB, Coleman RL, Chandra J, Sood AK. Merritt WM, et al. Among authors: spannuth wa. Cancer Biol Ther. 2009 Aug;8(16):1596-603. doi: 10.4161/cbt.8.16.9004. Epub 2009 Aug 13. Cancer Biol Ther. 2009. PMID: 19738426 Free PMC article.
Antitumor and antivascular effects of AVE8062 in ovarian carcinoma.
Kim TJ, Ravoori M, Landen CN, Kamat AA, Han LY, Lu C, Lin YG, Merritt WM, Jennings N, Spannuth WA, Langley R, Gershenson DM, Coleman RL, Kundra V, Sood AK. Kim TJ, et al. Among authors: spannuth wa. Cancer Res. 2007 Oct 1;67(19):9337-45. doi: 10.1158/0008-5472.CAN-06-4018. Cancer Res. 2007. PMID: 17909042
Bridging the gap between cytotoxic and biologic therapy with metronomic topotecan and pazopanib in ovarian cancer.
Merritt WM, Nick AM, Carroll AR, Lu C, Matsuo K, Dumble M, Jennings N, Zhang S, Lin YG, Spannuth WA, Kamat AA, Stone RL, Shahzad MM, Coleman RL, Kumar R, Sood AK. Merritt WM, et al. Among authors: spannuth wa. Mol Cancer Ther. 2010 Apr;9(4):985-95. doi: 10.1158/1535-7163.MCT-09-0967. Epub 2010 Apr 6. Mol Cancer Ther. 2010. PMID: 20371710 Free PMC article.
36 results